Replies to post #192269 on Biotech Values

[DewDiligence]

POZN—CEO, Adrian Adams bought $6.5M of stock on the open market 11/11/15 & 11/12/15 at an average price of about $6.50:

http://www.sec.gov/Archives/edgar/data/1059790/000110465915078424/xslF345X03/a4.xml

(Meanwhile, POZN’s former CEO, John Plachetka, who retired in Jun 2015, sold $1.05M of stock on 11/13/19:
http://www.sec.gov/Archives/edgar/data/1059790/000110465915079338/xslF345X03/a4.xml .)

p.s. POZN’s merger with TBIFF (and renaming of the merged company as Aralez) is expected to close in December.